Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Rapport Therapeutics

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
2022
51-100
Boston, Massachusetts, United States
BiotechnologynologyHealth CareLife ScienceMedicalPrecision Medicine

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

250.M

Last Funding Amount

150.M

Last Funding Date

23-08-2023

Startup Stage

IPO

Lead Investors

Cormorant Asset Management, Perceptive Advisors, ARCH Venture Partners, Fidelity, Third Rock Ventures

People

Founders